OTC Pharmaceuticals - Kuwait

  • Kuwait
  • The OTC Pharmaceuticals market in Kuwait is projected to generate a revenue of US$424.00m in 2024.
  • It is anticipated to experience an annual growth rate of 3.63% (CAGR 2024-2029).
  • Among the various markets, the Other OTC Pharmaceuticals market stands out as the largest with a market volume of US$98.76m in 2024.
  • When compared globally, the in the United States leads in revenue generation, reaching US$41,240.00m in 2024.
  • Considering the population figures, the per person revenue in Kuwait is estimated to be US$97.48 in 2024.
  • Furthermore, online sales are expected to contribute a minimal portion, amounting to 0.13% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • The OTC Pharmaceuticals market in Kuwait is witnessing a growing demand for natural and herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Kuwait is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this growth.Customer preferences play a crucial role in the development of the OTC Pharmaceuticals market in Kuwait. Consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. They prefer to have easy access to medicines without the need for a prescription or a visit to a doctor. This preference for self-medication has led to a surge in demand for over-the-counter pharmaceuticals.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in Kuwait. The increasing prevalence of lifestyle-related diseases, such as diabetes and hypertension, has resulted in a higher demand for OTC medications to manage these conditions. Moreover, the aging population in Kuwait is also driving the demand for OTC pharmaceuticals, as older individuals often require medication for chronic conditions.Local special circumstances further contribute to the growth of the OTC Pharmaceuticals market in Kuwait. The country has a well-developed healthcare infrastructure, with a large number of pharmacies and retail outlets offering a wide range of OTC medications. This accessibility and availability of OTC pharmaceuticals make it easier for consumers to purchase the products they need.Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Kuwait. The country has a high per capita income and a strong economy, which enables consumers to afford OTC medications. Additionally, the government of Kuwait has implemented policies to promote the growth of the healthcare sector, including the OTC pharmaceutical market. These policies include the establishment of regulatory frameworks to ensure the safety and quality of OTC medications.In conclusion, the OTC Pharmaceuticals market in Kuwait is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Consumers' preference for convenience and accessibility, the increasing prevalence of lifestyle-related diseases, the accessibility and availability of OTC medications, and the country's strong economy and supportive government policies all contribute to this growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)